Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Dudareva

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|August 15, 2021
Hepatitis B vaccination coverage in Germany: systematic reviewGyde Steffen, Ida Sperle, Thomas Harder, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 25, 2025
National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021Ludmila Kasatkina, Vladyslav Fedorchenko, Iryna Sidorova, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 17, 2017
Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014Sandra Dudareva-Vizule, Karin Haar, Andrea Sailer, et al.
Plos One|March 10, 2020
The epidemiology of Hepatitis B, C and D in Germany: A scoping reviewGyde Steffen, Ida Sperle, Siv Aina Leendertz, et al.
BMC Infectious Diseases|January 19, 2018
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistanceSusanne Buder, Sandra Dudareva, Klaus Jansen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020Arno Furquim d'Almeida, Erwin Ho, Christian Schüttler, et al.
BMC Infectious Diseases|July 18, 2020
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in GermanyRegina Selb, Klaus Jansen, Matthias Eckardt, et al.
BMJ Open|February 7, 2024
Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional studyAnahit Demirchyan, Sandra Dudareva, Serine Sahakyan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 8, 2024
Viral hepatitis knowledge and vaccination awareness among men who have sex with men (MSM) in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017Sofia Burdi, Michael Brandl, Ulrich Marcus, et al.
Frontiers in Public Health|June 7, 2021
Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019Anna Maisa, Christian Kollan, Matthias An der Heiden, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|August 15, 2021
Hepatitis B vaccination coverage in Germany: systematic reviewGyde Steffen, Ida Sperle, Thomas Harder, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 25, 2025
National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021Ludmila Kasatkina, Vladyslav Fedorchenko, Iryna Sidorova, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 17, 2017
Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014Sandra Dudareva-Vizule, Karin Haar, Andrea Sailer, et al.
Plos One|March 10, 2020
The epidemiology of Hepatitis B, C and D in Germany: A scoping reviewGyde Steffen, Ida Sperle, Siv Aina Leendertz, et al.
BMC Infectious Diseases|January 19, 2018
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistanceSusanne Buder, Sandra Dudareva, Klaus Jansen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020Arno Furquim d'Almeida, Erwin Ho, Christian Schüttler, et al.
BMC Infectious Diseases|July 18, 2020
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in GermanyRegina Selb, Klaus Jansen, Matthias Eckardt, et al.
BMJ Open|February 7, 2024
Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional studyAnahit Demirchyan, Sandra Dudareva, Serine Sahakyan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 8, 2024
Viral hepatitis knowledge and vaccination awareness among men who have sex with men (MSM) in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017Sofia Burdi, Michael Brandl, Ulrich Marcus, et al.
Frontiers in Public Health|June 7, 2021
Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019Anna Maisa, Christian Kollan, Matthias An der Heiden, et al.
Pageof 5